About FunPep
FunPep is a publicly listed company based in Shibuya (Japan) founded in 2013. Peptide-based therapeutics for skin disorders are developed. The company has 15 employees. Its website funpep.co.jp draws about 26 thousand monthly visits. Its focus areas include Life Sciences, Dermatology, Drugs and Diversified.
Company details
FunPep was established in 2013 in Shibuya, Japan, within the biotechnology sector. Peptide-based solutions are developed for treating skin disorders, including SR-0379, which supports fibroblast proliferation and angiogenesis to address skin ulcers. Antibody-inducing peptides such as FPP003, targeting IL-17A, are created for psoriasis management. FPP004, directed at IgE, is formulated to treat allergic conditions like pollinosis and seasonal allergic rhinitis.
- Headquarters Shibuya, Japan
- Employees 15
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website funpep.co.jp
- Legal Name Funpep Co., Ltd.
- Annual Revenue$2 K (USD)-94.88as on Dec 31, 2025
- Net Profit-$12.19 M (USD)-115as on Dec 31, 2025
- EBITDA-$10.28 M (USD)-87as on Dec 31, 2025
- Employee Count15
IPO & Listings of FunPep
FunPep is a publicly listed company on the TSE with ticker symbol 4881 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Dec 2020
- Listed onTSE: 4881
- Listed entityFunPep Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3802640007
- Share price44.00 JPY · 2026-10-14
- Market capitalisation2,229,334,732.00 JPY
- EPS (diluted, trailing year)-37.74 JPY
- Volume (last session)85,200
Financials of FunPep
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 314,000 JPY | -1.91B JPY | -1.61B JPY |
| 2024 | 6.1M JPY | -889.1M JPY | -859.2M JPY |
| 2023 | 530,000 JPY | -933.4M JPY | -950.5M JPY |
| 2022 | 1.1M JPY | -1.17B JPY | -1.16B JPY |
| 2021 | 126.9M JPY | -682.3M JPY | -743.7M JPY |
Detailed financial statements for FunPep
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of FunPep
The website of FunPep (funpep.co.jp) receives about 26.1K visits a month and ranks #1,152,941 among all websites worldwide, #1,441 in Biotechnology and Pharmaceuticals.
- Monthly visits26.1K
▲ 20.1% vs previous month
- Unique visitors11K
per month
- Global rank#1,152,941
among all websites
- Category rank#1,441
Health · Biotechnology and Pharmaceuticals
- Bounce rate73%
- Pages per visit2.3
- Average visit13 sec
- DevicesDesktop 27% · Mobile 73%
Websites whose visitors overlap most with FunPep. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| symbiopharma.com | 100% | 10.1K | #1,553,492 | View details | |
| nobelpharma.co.jp | 96% | 14K | #1,697,186 | View details | |
msd.co.jp | msd.co.jp | 87% | #1,046,821 | – | |
| kyorin-pharm.co.jp | 83% | 51.3K | #474,764 | View details | |
orthomedico.jp | orthomedico.jp | 83% | #1,718,435 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for FunPep
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Funpep
Complete news archive for FunPep
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FunPep
FunPep was founded in 2013.
FunPep is headquartered in Shibuya, Japan. It is registered at Shibuya, Tokyo, Japan.
FunPep has 15 employees.
Annual revenue of FunPep is $2K as on Dec 31, 2025.
FunPep was established in 2013 in Shibuya, Japan, within the biotechnology sector. Peptide-based solutions are developed for treating skin disorders, including SR-0379, which supports fibroblast proliferation and angiogenesis to address skin ulcers. Antibody-inducing peptides such as FPP003, targeting IL-17A, are created for psoriasis management. FPP004, directed at IgE, is formulated to treat allergic conditions like pollinosis and seasonal allergic rhinitis.
Yes, FunPep is publicly traded on TSE under the ticker symbol 4881.